“…This contact procedure is applied to benign changes, e.g. to hereditary and acquired vessel anomalies [6,48,49], or to benign prostate hyperplasia (BPH) [24,25,27,[35][36][37][39][40][41][42]44,45] as well as the destruction of malignant tumours or metastases. In the latter case, it is mainly a palliative treatment [1][2][3][4][5]7,8,12,14,16,18,20,22,25,[29][30][31][32][33][34]38,45,56,[60][61][62][63][64][65][66][67].…”